ClinicalTrials.gg
Active, not recruitingNCT04113044Updated Mar 6, 2026

Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®

An observational study in Hip Fractures, Tibial Fractures and Ankle Fractures, sponsored by AO Innovation Translation Center. Active, not recruiting at 15 sites in 6 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by AO Innovation Translation Center · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 25 studies in Hip Fractures with a site in Germany — 1 open to participants now, 9 under way, none of them phase 3. Hip Fractures · Germany.

Started
2021
with 3 others
Observational
9 of 25
none open now
Registered
17th of 25
by date
Lead sponsor
3 of 25
AO Innovation Translation Center

Among the 25 studies in Hip Fractures with a site in Germany, this one is one of 4 that started in 2021, is one of 9 observational ones, and was the 17th registered.

Hip Fractures

843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.

Browse Hip Fractures studies →

Open to participants now

1 of the 25 studies in Hip Fractures with a site in Germany is open now. Recruiting first, the newest first:

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Hip Fractures with a site in Germany, or all of them as a file.
02

Study summary

Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups).

Patients will be followed up according to the standard (routine) for up to 1 year after the treatment.

Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.

Read the detailed description

More in detail this observational study includes the following sub-projects:

I) Weight -bearing and Gait Observation for Fully Individualized Treatment and Aftercare Following Surgery and Trauma

Objectives:

To analyse the association between automated, sensor-based patient activity and loading data, and clinical (Patient Reported Outcomes [PROs]) and radiographic outcome during fracture healing.

II) Recovery Trajectory using PROMIS®: Defining the Recovery Trajectory using PROMIS® to Optimize Decision-making and Outcomes following Extremity Fractures

Objectives:

  1. To identify the factors predictive of longer term magnitude of limitations after extremity fractures (using PROMs)
  2. To assess minimal clinically important difference (MCID) and substantial clinical benefit (SCB) in PROM scores
  3. To define recovery trajectories of PROMs i.e. range, normative limits and score thresholds

III) Linking PROMIS®: Linking of PROMIS Measures to Legacy Measures in an Orthopaedic Patient Population

Objectives:

  1. Administer and collect responses to the PROMIS PF/UE and PAIN INT and the four orthopaedic legacy measures in the same group of orthopaedic trauma patients.
  2. Apply the methods of item-response theory (IRT) linking to establish a common standardized metric.
  3. Develop equations for conversion of a PROMIS PF/UE and PAIN INT score to each of the specified legacy measures and vice-versa.
03

Conditions studied

  • Hip Fractures
  • Tibial Fractures
  • Ankle Fractures
  • Humeral Fracture, Proximal
  • Distal Radius Fracture

Keywords

  • PRO
  • HOOS
  • KOOS
  • FAAM
  • PROMIS
  • QuickDASH
  • PSEQ
  • PAM
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All patients over 18 who have have suffered an isolated fracture of one of the following five bones: 1. proximal femur (hip); 2. tibial shaft (shin bone); 3. ankle; 4. proximal humerus (shoulder); and 5: distal radius ( wrist)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years and older
  • Diagnosis of one of, isolated injury

    • Hip fracture
    • Tibial shaft fracture (with and without associated fibular fracture)
    • Ankle/pilon fracture
    • Proximal humerus fracture
    • Distal radius fracture
  • English, German, or Spanish speaking
  • obtained, i.e.:

    • Ability to understand the content of the patient information/ICF
    • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
    • Signed and dated EC/IRB approved written informed consent

Exclusion criteria

Exclusion Criteria:

  • More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision
  • Patients with multiple fractures
  • Pathological fractures due to cancer
  • Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the study period
  • Patients who are not able to provide independent written unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place
  • Prisoners
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
  • Patients unable to likely achieve anticipated Follow-up (FU)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Interventions

  • OtherAll treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

    All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

    Also known as: Patient Reported Outcomes

06

What researchers measure

Primary outcomes

  1. Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysis

    * Radiographic measurements o Healing (Radiographic Union Score in Tibia Fractures \[RUST\]/ Radiographic Union Score in Hip Fractures \[RUSH\]) * Patient related outcomes * Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference * Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms) * Knee Injury and Osteoarthritis Outcome Score (KOOS-12) (assessing short- and long-term symptoms and function in knee injuries; the lower score indicates higher symptoms) * Loading/Activity pattern analysis: * Number of steps with weight-bearing \>80% body-weight (weight in kg) * pressure distribution \[N/cm2\] * center of pressure \[mm\] * ground reaction forces \[N\] * temporal and spatial parameters (time spent during gait \[min\], stance time \[s\], swing time \[s\], double support time \[s\], cadence \[r/min\], cycle time \[s\])

    Time frame: from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)

  2. Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAM

    PROs that measure physical limitations: * PROMIS PF Short Form Custom AO14 (questions that cover the domain of physical function/mobility from self-care to strenuous activities) * PROMIS Upper Extremity (UE) Short Form Custom AO8 (questions assessing arm and hand specific limitations, e.g. difficulty writing, lifting heavy objects; a higher score indicates a better function) * Disabilities of the Arm, Shoulder, and Hand (QuickDASH) (11 questions assessing outcomes in upper extremity disorders; a higher score indicates a greater disability) * HOOS-12 * KOOS-12 * Foot and Ankle Ability Measure (FAAM) (21 items of activities of daily living subscale) * PROMIS Global Health (10 questions assessing physical health, mental health, and social health; a higher score indicates a better general health)

    Time frame: from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)

Secondary outcomes

  1. PROMIS Pain Interference

    PROMIS Pain Interference (8 questions) assesses the impact of pain on common activities of daily life including social, cognitive, emotional, physical, and recreational aspects. The higher score represents a higher pain level

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  2. PROMIS Depression

    PROMIS Depression assesses negative mood (sadness, guilt), views of self (worthlessness, self-criticism) and diminished positive affect and engagement (loss of interest) within the previous week. The higher score represents higher depression level

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  3. PROMIS Anxiety

    PROMIS Anxiety assesses levels of anxiety through measuring aspects of fear (e.g. fearfulness, feelings of panic), anxious misery (e.g. worry, dread), hyperarousal (e.g. tension, nervousness, restless) and some somatic symptoms related to arousal (e.g. dizziness). The higher score represent the higher level of anxiety

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  4. PROMIS Ability to Participate in Social Roles and Activities

    PROMIS Ability to Participate in Social Roles and Activities item bank assesses the perceived ability to perform one's usual social roles and activities. The higher score represents better ability for social roles

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  5. Pain Self-Efficacy Questionnaire (PSEQ)-2

    PSEQ-2 assesses adaptive coping strategy and the confidence one can achieve one's goals in spite of pain. Items are scored on a 7-point Likert scale and added to form a total score ranging from 0 to 12, with higher scores indicating greater self-efficacy

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  6. Patient Activation Measure (PAM)-10

    PAM-10 assesses activation and the personal and psychological competencies. PAM segments individuals into one of four activation levels along an empirically derived 100-point scale. Individuals in the highest activation level are proactive with their health, have developed strong self-management skills, and are resilient in times of stress or change.

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  7. Cognitive assessment

    The MiniCog is a 3-minute instrument assessing cognitive impairment. It consists of two components, a 3-item recall test for memory and a simply scored clock drawing test. A total score ranges from 0 to 5. A score of zero, one or two out of five points in total, indicates a concern in cognitive functioning.

    Time frame: Pre-treatment

  8. Mobility Scores

    Parker Mobility Scale assess the patient's ability to perform indoor walking, outdoor walking, and shopping before the fracture. A score ranges between 0 and 3 (0 = not at all, 1 = with help from another person, 2 = with an aid, and 3 = no difficulty and no aid) for each function, resulting in a total score ranging from 0 (no walking ability at all) to 9 (fully independent).

    Time frame: Pre-treatment

  9. RUSH score

    Radiographic Union Score in Hip Fractures

    Time frame: from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)

  10. RUST score

    Radiographic Union Score for Tibia

    Time frame: from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)

  11. Numeric Rating Scale (NRS) Pain

    An ordinal scale from 0 to 10 with 0 indicating no pain and 10 indicating extreme pain.

    Time frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

07

Study locations

15 sites
08

References and documents

Publications

  • AOBERT Consortium. Optimising the utility of patient-reported outcome measurements during recovery after orthopaedic extremity fractures: protocol for a multicentre prospective cohort study. BMJ Open. 2026 May 6;16(5):e113927. doi: 10.1136/bmjopen-2025-113927. PubMed 42091143 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2021 (actual). Primary completion is estimated for Dec 2026, 70 months after the start.

Of 107 non-industry observational studies under Hip Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 65. This study's planned 70 months is above that.

Counting every sponsor, half of 124 studies reached it within 28 months; a quarter within 12 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 20, 2019
First posted
Oct 2, 2019
StartActual
Feb 1, 2021
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04113044
Lead sponsor
AO Innovation Translation Center
Responsible party
Sponsor
First posted
Oct 2, 2019
Start date
Feb 1, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 6, 2026

Study contacts

Marilyn Heng
principal investigator · Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
Prakash Jayakumar
principal investigator · Dell Medical School, University of Texas at Austin
Tim Pohlemann
principal investigator · Saarland University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion